Investigator Initiated Grants (John D. Carter, MD)

  • Regional Grants in Aid (RGIA)

"The Effect of a Low Carbohydrate, High Protein/Fat Diet on Bone Turnover."
Granting Agency: Procter & Gamble (Investigator Initiated Grant)
Awarded August 2004
Completed May 2006; published 2006
Amount Awarded: $17,675.00
Principal Investigator

  • Unrestricted Fellowship Educational Grant

"Training Fellows to Perform Clinical Research."
Granting Agency: Amgen
Awarded August 2004
Completed December 2004
Amount Awarded: $2500.00
Principal Investigator

  • Investigator Initiated Grants Initiative

"Male Osteoporosis: Recognition & Treatment."
Granting Agency: Merck (Investigator Initiated Grant)
Awarded October 2004Project completed; manuscript in press
Amount Awarded: $24,835.00
Principal Investigator

  • NIH Exploratory/Developmental Research Grant Award (R21)

"Combination Antimicrobial Therapy as a Treatment for Chlamydia-Induced Reactive Arthritis."
National Institutes of Health (National Institute of Musculoskeletal and Skin Diseases [NIAMS])
International Multi-Center Trial (4 Study Sites)
Assignment Number: 1 R21 AR053646-01
Start Date May 22, 2006
Stop Date April, 2009
Amount Awarded: $415,031.00
Principal Investigator

  • A Safety Analysis of Oral Prednisone as a Pre-Treatment for Rituximab in Rheumatoid Arthritis."

Sponsor: Genentech
Amount: $501,125.00 (with the potential of $698,945.00 based on study extension)
Status: Regulatory & Trial Initiation Phase
Project: November, 2006 – January, 2010
Target Enrollment: 50 patients
Principal Investigator

  • MRI and Ultrasound Findings in Patients with Gout and Normal Plain Radiographs."

Sponsor: TAP Pharmaceuticals
Principal Investigator

  • "Shifting the Paradigm of Gout: An Assessment of Chronic Synovial-Based Inflammation and its Role with Serum Urate Levels."

Sponsor: Takeda Pharmaceuticals
Principal Investigator